GEN HealthCare Protection

GEN HealthCare Protection is Generali’s flagship as-charged hospital rider, sold as an attachment to a Generali base life policy (in the published illustrations, GEN Proteksi Utama). It is not a standalone health product — the customer must hold a Generali base contract underneath it. The structure is annually renewable, as-charged (sesuai tagihan), with six geographic plan tiers running from Indonesia-only at the bottom (Gold Standard / Gold Deluxe) up to worldwide-ex-USA at the top (Titanium), and an annual benefit cap that scales from Rp 3B at the entry tier to Rp 15B at Titanium. Inpatient and outpatient are both covered (rare combination at this price band) — outpatient includes cancer treatment (radiotherapy, chemotherapy, immunotherapy, targeted, hormonal, oral), dialysis, post-stroke rehabilitation, and outpatient psychiatric consultation. Two signature mechanics differentiate it: a No Claim Discount worth up to 15% off renewal premium after three consecutive claim-free observation periods, and a No Claim Bonus that lifts the initial lifetime limit (Batas Seumur Hidup Awal) by 10% per claim-free anniversary up to a 50% cumulative uplift. The product also offers an optional Lite Saver co-payment toggle (10% or 20% customer share) that meaningfully reduces premium — and that toggle now operates inside the operative POJK 36/2025 co-payment regime that took effect January 2026 and has been live for ~5 months.

In one line: Strong cancer + outpatient coverage with six geographic tiers, no-claim incentives that compound over years, and a customer-elected co-payment that lowers premium but exposes the customer to layered cost-share under the now-operative POJK 36/2025 minimum co-pay rules.

---

The RIPLAY publishes two sample cases — both for a 30-year-old male, Plan Gold Deluxe (Indonesia coverage), monthly premium frequency. We work from those:

Critical insight for the agent narrative: the headline “Rp 60 miliar limit” in Generali marketing is Batas Tahunan + Batas Seumur Hidup Awal at the Titanium tier — that is the worldwide-ex-USA tier and a cumulative lifetime construct, not a yearly cap. For most prospects who buy Gold or Diamond tiers, real exposure is much smaller. Frame this honestly when comparing against Allianz Flexi Medical’s Rp 15–20B annual cap.

---

Sweet Spot — Existing Generali base-policy holders being upsold

• Age 28–50, married, 1–3 dependents
• Already holds a Generali base life policy (GEN Proteksi Utama, GEN Prime Link, BeSmart, etc.) — Gen HealthCare Protection cannot be sold standalone
• Household income Rp 20M+/month
• Wants both inpatient and outpatient cover in a single product (vs Allianz Flexi Medical, which is indoor-focused)
• Sees cancer as a primary fear — chemotherapy and radiotherapy outpatient cover is a meaningful win for this product
• Healthy at point of sale (12-month specific-disease waiting list is long and broad — hypertension, diabetes, cancer, kidney, gallbladder, ENT, vertebral disc are all on it)
• Willing to opt into a 10% or 20% co-payment toggle in exchange for lower premium

Borderline Fit — Discuss but qualify carefully

• Age 51–65 — entry permitted; renewable to age 90; premiums escalate with age and product publishes no guarantee on future tariffs (RIPLAY explicitly: “Penanggung tidak menjamin atau menjanjikan besarnya Premi”)
• Customers comparing tiers across Indonesia, Asia, and Worldwide — geographic tier complexity is genuine; pick wrong tier and customer pays balance-bill exposure when treated overseas
• Customers attracted by the “Rp 60 miliar” marketing line — verify they understand it is Titanium tier (the most expensive plan) and that the figure is annual + lifetime, not annual alone
• High-utilization households (frequent outpatient, chronic conditions) — Lite Saver co-pay can become punitive; pure no-Lite-Saver plan is more honest

Do Not Pitch

• Customers without an existing Generali base policy and not willing to buy one — Gen HealthCare Protection is a rider, not standalone
• Customers expecting USA treatment — explicitly excluded across all tiers including Titanium
• Customers expecting dental, optical, maternity, congenital, or fertility cover — all excluded (Sections 12, 17, 18 of the exclusion list)
• Customers with diagnosed hypertension, diabetes, cancer history, kidney stones, hernia, or HNP — the 12-month specific-disease waiting list captures most of these and the pre-existing exclusion stacks on top
• Customers who want a fixed lifetime premium — annual renewable; insurer reserves right to increase tariff at every renewal

---

This is competitive intelligence for Legacy Income agents who sell Allianz Flexi Medical or Allianz Preferred Medical. Generali is not a Legacy Income benchmark; the goal here is to know where Gen HealthCare Protection has a genuine structural win and where Allianz wins.

Rule of thumb: if the customer says “saya sudah punya Generali” or “saya butuh rawat jalan kanker yang lengkap” or “saya sering ke luar negeri”, Gen HealthCare Protection is in the conversation. If they say “saya mau satu polis untuk seluruh keluarga termasuk orang tua dan adik” or “saya mau cap tahunan setinggi mungkin tanpa lifetime cap” or “tidak mau ada co-payment”, they will be better served by Allianz Flexi Medical.

---

Per category-benchmarks.json health section, the Indonesia agency health category currently shows 100% PDF coverage on the catalogued set, but the quantitative metrics (annual cap median, room rate median, deductible distribution) do not yet meet the 60% category-coverage threshold for confident statistical claims. The benchmarking below is therefore qualitative.

Confidence note: Structural dimensions are high-confidence from the RIPLAY (re-validated against the byte-identical 2026-05-24 download). Quantitative competitor comparisons are analyst judgment from category knowledge plus the canonical Allianz briefs; not directly benchmarked against parsed competitor RIPLAYs because health-category metric extraction does not yet meet the 60% threshold. Refresh trigger: when health-category PDF metric extraction passes the 60% threshold.

---

For Legacy Income agents, these are designed as counter-positioning points — to be used when a prospect surfaces Gen HealthCare Protection in conversation. They are not Generali sales scripts.

Opening — establish the protection frame

“Good that you’re looking at Generali — they have a respectable health rider. Before you commit, there are three structural questions worth asking. First, do you already hold a Generali base policy? Second, do you want outpatient cancer plus general inpatient, or mostly inpatient? Third, who else in the family needs cover? Your answers will tell us whether Generali fits or whether we should compare against an Allianz plan.”

“Bagus Anda lagi lihat Generali — rider kesehatan mereka cukup kompetitif. Sebelum commit, ada tiga pertanyaan struktural yang penting. Pertama, apa Anda sudah pegang polis dasar Generali? Kedua, Anda butuh rawat jalan kanker plus rawat inap, atau fokus rawat inap saja? Ketiga, siapa lagi di keluarga yang butuh cover? Jawaban Anda akan menentukan apakah Generali cocok, atau apakah kita sebaiknya bandingkan dengan plan Allianz.”

The structural counter-point (the rider-only constraint)

“One thing to be clear about: Gen HealthCare Protection is a rider — you cannot buy it on its own. You need a Generali base life policy underneath, which adds premium on top of the health premium. If you already hold that base policy, fine. If you don’t, you’re paying for a life policy you may not have planned to buy, just to access the health rider. Allianz Flexi Medical can be sold on its own — that’s a meaningful structural difference.”

“Satu hal yang perlu jelas: Gen HealthCare Protection itu rider — tidak bisa dibeli sendiri. Anda harus punya polis dasar Generali, dan itu menambah premi lagi di atas premi kesehatan. Kalau memang sudah punya polis dasarnya, oke. Kalau belum, Anda bayar polis jiwa yang mungkin tidak Anda rencanakan, hanya untuk akses ke rider kesehatannya. Allianz Flexi Medical bisa berdiri sendiri — itu bedanya yang material.”

The Lite Saver / co-payment honesty (the regulatory layer is now live)

“Lite Saver looks attractive — premium goes down 10 to 20 percent if you accept a 10 or 20 percent share of each claim. But the OJK regulation POJK 36/2025 is already in force — it took effect January 2026 and has been live for about five months. That regulation introduces a minimum customer co-payment for health insurance industry-wide. We need to walk through how Lite Saver interacts with the regulatory minimum, because in many cases the customer’s exposure layers — you pay the Lite Saver share and the regulatory minimum. I’d rather you see the full picture before signing.”

“Lite Saver kelihatannya menarik — premi turun 10 sampai 20 persen kalau Anda terima 10 atau 20 persen dari setiap klaim. Tapi peraturan OJK POJK 36/2025 sudah berlaku — efektif Januari 2026 dan sudah jalan sekitar lima bulan. Peraturan itu memperkenalkan co-payment minimum untuk asuransi kesehatan secara industri. Kita perlu lihat bagaimana Lite Saver bekerja dengan minimum regulator itu, karena di banyak kasus exposure nasabah berlapis — Anda bayar share Lite Saver dan minimum regulator. Saya lebih suka Anda lihat gambar lengkapnya sebelum tanda tangan.”

The signature feature acknowledgment — outpatient cancer breadth

“Where I’ll give Generali credit honestly: outpatient cancer treatment coverage is comprehensive. All five cancer modalities — radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy — are in product, including oral chemotherapy and post-treatment remission monitoring. If outpatient cancer is your single biggest concern, this is a genuine strength of the Generali design. Allianz also covers cancer treatment but the breadth of outpatient modalities is something Generali emphasizes structurally.”

“Yang harus saya akui jujur tentang Generali: cover rawat jalan kanker mereka lengkap. Lima modalitas kanker — radioterapi, kemoterapi, imunoterapi, targeted therapy, terapi hormonal — semuanya in-product, termasuk kemoterapi oral dan pemantauan remisi. Kalau kanker rawat jalan jadi concern terbesar Anda, ini memang kekuatan struktural Generali. Allianz juga cover kanker, tapi breadth modalitas rawat jalan adalah hal yang Generali tonjolkan secara struktural.”

The close — when to pitch Allianz alternative

“If your situation is: existing Generali base policy + cancer outpatient is the primary fear + Indonesia or Asia-only treatment intent + you accept the rider-only constraint — Gen HealthCare Protection is reasonable. If any of those flips — no base policy, family of five to cover, want highest annual cap, want a clean standalone product — let’s compare side by side with Allianz Flexi Medical. I’ll bring both RIPLAYs and we walk through them together.”

“Kalau situasi Anda: sudah pegang polis dasar Generali + rawat jalan kanker adalah ketakutan utama + treatment di Indonesia atau Asia + Anda terima konstruksi rider-only — Gen HealthCare Protection masuk akal. Kalau salah satu dari itu berbeda — belum ada polis dasar, keluarga lima orang, mau cap tahunan tertinggi, mau produk standalone yang bersih — mari bandingkan side by side dengan Allianz Flexi Medical. Saya bawa kedua RIPLAY dan kita bedah bareng.”

—

1. “BPJS sudah cover rawat inap. Kenapa perlu ini lagi?”

“BPJS already covers hospitalization. Why do I need this?”

Don't say “BPJS is bad.” — confrontational; the customer chose BPJS as a baseline for a reason.

Don't say “BPJS jelek.”

Do say “BPJS is your foundation, and that’s good. What private health rider adds is three things BPJS struggles with: speed (no months-long queue for the specialist you want), choice (you decide which private hospital, not the BPJS rujukan chain), and class (private room vs ward). If your family hits cancer or stroke, BPJS will treat you eventually, but for the first weeks when timing matters most, private cover puts you in a better position. Most of my clients keep BPJS and layer this on top.”

Do say “BPJS adalah fondasi Anda, dan itu bagus. Yang ditambahkan oleh rider kesehatan swasta itu tiga hal yang BPJS struggle: kecepatan (tidak ada antri berbulan-bulan untuk spesialis yang Anda mau), pilihan (Anda yang pilih rumah sakit swasta, bukan rantai rujukan BPJS), dan kelas (kamar privat bukan bangsal). Kalau keluarga Anda kena kanker atau stroke, BPJS akan rawat — tapi minggu-minggu pertama yang paling penting, cover swasta menempatkan Anda di posisi lebih baik. Kebanyakan nasabah saya keep BPJS dan layer ini di atasnya.”

—

2. “Kantor saya sudah kasih asuransi kesehatan.”

“My company already provides medical insurance.”

Don't say “Your company’s plan is not enough.” — disrespects the customer’s employer and current arrangement.

Don't say “Asuransi kantor tidak cukup.”

Do say “That’s a great baseline. Two questions to walk through. First, what happens when you leave that company — retirement, resignation, layoff — at age 55 or 60, when private health premium based on a new application would be expensive and exclusions would be likely? A personally-owned policy bought now locks in your underwriting at today’s health. Second, family scope — your company plan usually covers spouse and minor children, but not parents and rarely siblings; this product (or alternatives) can fill that. The personal layer is not a duplicate; it’s continuity insurance for when the employer link ends.”

Do say “Itu baseline yang bagus. Dua pertanyaan untuk dibahas. Pertama, apa yang terjadi saat Anda keluar dari perusahaan itu — pensiun, resign, atau di-PHK — di umur 55 atau 60, saat premi asuransi swasta berdasarkan aplikasi baru akan mahal dan exclusion pasti banyak? Polis pribadi yang dibeli sekarang mengunci underwriting di kondisi kesehatan hari ini. Kedua, scope keluarga — plan kantor biasanya cover istri dan anak kecil, tapi tidak orang tua dan jarang adik; produk ini (atau alternatif) bisa mengisi itu. Lapisan pribadi bukan duplikasi; ini insurance kontinuitas saat kaitan dengan kantor putus.”

—

3. “Premi naik tiap tahun. Saya khawatir tidak sanggup nanti.”

“The premium rises every year. I’m worried I won’t be able to afford it later.”

Don't say “The premium won’t rise.” — the RIPLAY itself states the insurer reserves the right to raise tariff; you’ll be caught.

Don't say “Premi tidak bakal naik.”

Do say “Honest answer: yes, premium rises with age and medical inflation. Indonesia’s medical inflation is running 20–26 percent per year. The RIPLAY says clearly the insurer reserves the right to raise tariff at each renewal. What can offset that: Gen HealthCare Protection has No Claim Discount (up to 15 percent off if you stay claim-free three years running) and No Claim Bonus (Initial Lifetime Limit grows up to 50 percent if claims stay low). Allianz Flexi Medical has Flexi Benefit cashback (5 to 20 percent from year three onward). Neither eliminates escalation — but both reward staying healthy. Buying now at your current age locks the lowest entry point you’ll ever see.”

Do say “Jawab jujur: ya, premi naik seiring usia dan inflasi medis. Inflasi medis Indonesia berjalan 20–26 persen per tahun. RIPLAY-nya sendiri bilang penanggung berhak naikkan tarif setiap perpanjangan. Yang bisa offset: Gen HealthCare Protection punya No Claim Discount (sampai 15 persen kalau Anda tetap tanpa klaim tiga tahun berturut-turut) dan No Claim Bonus (Batas Seumur Hidup Awal naik sampai 50 persen kalau klaim tetap kecil). Allianz Flexi Medical punya Flexi Benefit cashback (5 sampai 20 persen mulai tahun ketiga). Tidak ada yang eliminasi kenaikan — tapi keduanya reward Anda yang tetap sehat. Beli sekarang di umur Anda saat ini adalah entry point termurah yang akan pernah Anda lihat.”

—

4. “Saya sehat. Jarang ke dokter. Buang-buang uang.”

“I’m healthy. Rarely see a doctor. This is a waste of money.”

Don't say “You’ll get sick.” — fear-based and disrespectful.

Don't say “Anda pasti akan sakit.”

Do say “I understand. Most healthy people feel exactly that, right up until one event changes everything. A single stroke event in a private hospital in Jakarta runs Rp 150 to 250 million across 30 to 45 days of care. An ICU admission with ventilator support is Rp 20 to 30 million per day. The question isn’t ‘will I use it this year.’ The question is ‘can I write a cheque for Rp 200 million on the worst day of my life and still keep my family’s lifestyle intact?’ If the answer is yes, you don’t need this. If the answer is no, this is the insurance against the one expensive day you cannot predict. And the no-claim discount mechanic means you’re rewarded financially for staying healthy.”

Do say “Saya paham. Kebanyakan orang sehat merasa persis seperti itu, sampai satu event mengubah semuanya. Satu kejadian stroke di rumah sakit swasta Jakarta habis Rp 150 sampai 250 juta untuk 30–45 hari perawatan. Admisi ICU dengan ventilator Rp 20 sampai 30 juta per hari. Pertanyaannya bukan ‘apakah saya akan pakai tahun ini.’ Pertanyaannya ‘apakah saya bisa tulis cek Rp 200 juta di hari terburuk hidup saya dan tetap menjaga lifestyle keluarga utuh?’ Kalau jawabnya iya, Anda tidak butuh ini. Kalau jawabnya tidak, ini insurance untuk satu hari mahal yang tidak bisa Anda prediksi. Dan mekanika no-claim discount artinya Anda di-reward secara finansial kalau tetap sehat.”

—

5. “Saya khawatir klaim ditolak. Banyak exclusion.”

“I’m worried my claim will be rejected. Lots of exclusions.”

Don't say “There are no exclusions.” — the RIPLAY lists 29 exclusion paragraphs; this lie will be caught at the first claim.

Don't say “Tidak ada exclusion.”

Do say “Standard health insurance does have exclusions — it’s universal across the industry, not unique to Generali. The big ones in Gen HealthCare Protection are: pre-existing conditions (excluded unless underwritten in writing), 30-day general waiting, 90-day cancer waiting, 12-month specific-disease waiting covering hernia, hypertension and cardiovascular, kidney stones, gallbladder, all tumors and cancer, ENT, vertebral disc, thyroid, and a few more. Plus standard exclusions: USA treatment, dental except accident, pregnancy and fertility, congenital, mental health (except outpatient psychiatric carve-out), epidemics by default. Before we file the SPAJ, we walk through the full list and flag anything in your medical history. If your father has diabetes that you don’t have, that’s fine for your application; if you have diagnosed hypertension, we disclose it and either get a rider or accept the exclusion on application. No surprises later. I’ll show you the RIPLAY exclusion section now.”

Do say “Asuransi kesehatan standar memang punya exclusion — ini universal di industri, bukan unik Generali. Yang besar di Gen HealthCare Protection: kondisi sudah ada (excluded kecuali di-underwrite tertulis), masa tunggu umum 30 hari, masa tunggu kanker 90 hari, masa tunggu penyakit khusus 12 bulan cover hernia, hipertensi dan kardiovaskular, batu ginjal, empedu, semua tumor dan kanker, THT, HNP, kelenjar tiroid, dan beberapa lainnya. Plus exclusion standar: treatment USA, gigi kecuali kecelakaan, kehamilan dan kesuburan, kongenital, kesehatan mental (kecuali carve-out psikiatri rawat jalan), pandemi by default. Sebelum kita ajukan SPAJ, kita walk through full list dan flag apa pun di history medis Anda. Kalau ayah Anda diabetes tapi Anda tidak — itu oke untuk aplikasi Anda; kalau Anda diagnosed hipertensi, kita disclose dan minta rider atau terima exclusion di aplikasi. Tidak ada kejutan nanti. Saya tunjukkan section exclusion RIPLAY sekarang.”

—

These are the issues most likely to trigger an OJK complaint or repudiated claim under the tightened 2026 conduct rules. Apply these as Legacy Income agent-training checklist items even when the comparison product is Gen HealthCare Protection rather than the Allianz line, because pre-sale misrepresentation by any agent on a competitor product creates churn-back risk for the entire affluent health-insurance category.

1. POJK 36/2025 co-payment regime — operative since January 2026, applies to all health insurance contracts. POJK 36/2025 is now ~5 months in force. It mandates a minimum customer co-payment exposure on health insurance contracts industry-wide. Generali Gen HealthCare Protection sells a customer-elected Lite Saver toggle (10% or 20%) layered on top of plan structure. Agents must walk customers through the combined exposure — Lite Saver share + POJK 36/2025-mandated minimum — at the SPAJ stage, and document customer acknowledgment in writing. Selling a “no Lite Saver” plan and telling the customer “you have no co-payment” is mis-selling: the regulatory minimum applies regardless of Lite Saver toggle. OJK implementation guidance for Lite-Saver-stacking on customer-elected co-pay products has not yet been published; treat conservatively and document interpretation chosen until OJK clarifies. Refresh trigger: OJK guidance publication.

2. Pre-existing condition exclusion + 12-month specific-disease waiting list. Gen HealthCare Protection’s specific-disease waiting list is among the broadest in the catalogued health set: hernia, all tumors and cancer, hypertension, cardiovascular, stroke and cerebrovascular, kidney and urinary stones (including kidney failure), gallbladder, thyroid, vertebral disc/HNP, blood disorders, varicose veins, peptic ulcer, and more. A customer with undiagnosed hypertension or borderline diabetes who is hospitalized within 12 months of inception will face claim repudiation. Agent must walk the specific-disease list during application and probe family history. If anything is questionable, request medical underwriting upfront rather than risking repudiation later.

3. Rider-only structure disclosure. Gen HealthCare Protection cannot be purchased standalone — it requires a Generali base life policy. The sample case in the RIPLAY shows the base policy adds Rp 12,400 per month, which is small relative to the rider but is still a structural obligation. Customers must understand they are committing to both contracts, not just the health rider. Document this on the application.

4. Plan tier vs actual hospital choice mismatch (balance billing). Gen HealthCare Protection has six tiers with different room-and-board caps (Rp 500K to Rp 2.2M per day). If a customer in Gold Standard tier (Rp 500K cap) is admitted to a Rp 1.5M-per-day room, they pay the balance. Selling Gold Standard or Diamond Superior to a customer who expects 1-bed private rooms at top private hospitals is mis-selling. Walk the customer through their preferred hospital and verify the chosen tier’s room cap covers it.

5. Geographic tier mismatch. Customers comparing Diamond Superior vs Diamond Deluxe (both “Asia ex-Singapore, Hong Kong, Japan”) often miss that Singapore, Hong Kong, and Japan are excluded from the Diamond Superior/Deluxe coverage — for those high-cost hubs, the customer needs Platinum Deluxe (Asia full) or Titanium (Worldwide ex-USA). A customer who flies to Singapore General Hospital expecting full cover under Diamond tier will be reimbursed only at 30% of bill. Verify treatment-intent geography during sale.

6. Cashless availability after 24 months only. Cashless claims are available after the rider has been in force 24 months. Before that, claims are reimbursement-based: customer pays first, claims back later. Customers who expect cashless from day one will be unpleasantly surprised. Walk this through during pitch.

7. Headline “Rp 60 miliar limit” framing. Brochure marketing line “limit kesehatan hingga Rp60 miliar” combines Batas Tahunan + Batas Seumur Hidup Awal at the Titanium tier plus the +50% No Claim Bonus uplift. It is a lifetime cumulative construct, not an annual cap. Most Gold/Diamond-tier customers will never see anything close to Rp 60B. Agents who lead with this figure without explaining the tier and cumulative-lifetime mechanic are creating mis-selling exposure.

---

---

1. Build a “Gen HealthCare Protection vs Allianz Flexi Medical / Preferred Medical” comparison handout in EN + ID, one A4 page max. Cover: standalone vs rider; family-package capacity; annual cap by tier; outpatient cancer breadth; co-payment design; no-claim mechanics; geographic tiers. Target deployment in agent kit by end of May. This is the single highest-leverage competitive-intel asset for Legacy Income agents who encounter Generali in the affluent health-insurance market.

2. POJK 36/2025 co-payment customer handout — overdue, deploy this week. POJK 36/2025 has been operative since January 2026 (~5 months live). Customer-level walkthroughs remain inconsistent across the industry, which is now a live mis-selling risk rather than a forward-looking one. Build (or finalize, if drafted earlier) a one-page customer handout explaining: (a) what POJK 36/2025 requires, (b) how it interacts with insurer-specific co-payment design (Allianz deductible structure + Generali Lite Saver toggle), © typical exposure scenarios with worked numbers. Have every Allianz Flexi Medical and Preferred Medical prospect sign it at SPAJ stage. This protects the agency from mis-selling complaints and gives agents a structured way to differentiate against competitors who don’t walk customers through the regulatory layer.

3. Agent talking-points training on POJK 36/2025 specifically. Two-hour internal session covering: (a) the regulation text and effective date (Jan 2026, now operative); (b) the Allianz Flexi Medical / Preferred Medical pricing implications; © how competitors are layering co-payment (Generali Lite Saver, Manulife and AIA equivalents); (d) the SPAJ-stage walkthrough checklist. Defer field deployment of any new health pitch until agents pass a short knowledge check. Estimated training cohort: all active health-selling agents.

4. Identify prospect overlap with Generali base-policy holders. Where Legacy Income’s CRM shows a prospect already holds GEN Proteksi Utama, GEN Prime Link, BeSmart, or another Generali base policy, the rider-only sales pathway gives Generali a structural advantage on Gen HealthCare Protection. Reposition Allianz pitch to those prospects as: (a) standalone alternative (no base-policy obligation), or (b) layered protection if their Generali rider has gaps in family scope or annual cap. Don’t try to displace a healthy Generali base policy mid-term; lead with what Allianz adds, not what Allianz replaces.

5. Refresh trigger and monitoring. Re-run this brief when: (a) OJK publishes POJK 36/2025 implementation guidance (clarifies Lite-Saver-stacking question — still pending as of 2026-05-27), (b) health-category metric extraction passes the 60% threshold (enables quantitative competitor comparison), or © Generali publishes a refreshed RIPLAY for Gen HealthCare Protection (current version still 1.1/X/2025 — 2026-05-24 download confirms no version bump; track via Daily Product Monitor). Until then, this brief and the Allianz Flexi Medical 2026-04-27 brief together remain the primary internal references for Legacy Income’s Allianz-vs-Generali positioning in the health-rider segment.

---